| scholarly article | Q13442814 |
| P2093 | author name string | Daniel G Maluf | |
| Valeria R Mas | |||
| Thu H Le | |||
| P2860 | cites work | Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy | Q71324547 |
| Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant | Q80470308 | ||
| Microarray analysis of MicroRNA expression in acute rejection after renal transplantation | Q80887475 | ||
| Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells | Q81338247 | ||
| DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy | Q82848506 | ||
| Intragraft gene expression in positive crossmatch kidney allografts: ongoing inflammation mediates chronic antibody-mediated injury | Q83450180 | ||
| Miles to go… | Q84284647 | ||
| Improving long-term outcomes for transplant patients: making the case for long-term disease-specific and multidisciplinary research | Q85013471 | ||
| Mechanisms of tubulointerstitial fibrosis | Q85074102 | ||
| Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury | Q85710754 | ||
| MicroRNA-21 attenuates renal ischemia reperfusion injury via targeting caspase signaling in mice | Q85813125 | ||
| Examination of serum miRNA levels in kidney transplant recipients with acute rejection | Q87301005 | ||
| Epigenetic modifications in cancer | Q22242610 | ||
| Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease | Q24289344 | ||
| The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 | Q24608778 | ||
| New loci associated with kidney function and chronic kidney disease | Q24630646 | ||
| MicroRNA profiling: approaches and considerations | Q26861675 | ||
| Fibroblasts in fibrosis: novel roles and mediators | Q26998508 | ||
| Histone deacetylases as targets for treatment of multiple diseases | Q27000389 | ||
| Regulation of skeletal muscle development and homeostasis by gene imprinting, histone acetylation and microRNA | Q27001499 | ||
| Epigenetics of progression of chronic kidney disease: fact or fantasy? | Q27005788 | ||
| Treg functional stability and its responsiveness to the microenvironment | Q27008946 | ||
| Dynamic nature of noncoding RNA regulation of adaptive immune response | Q27012604 | ||
| Proteomics and metabolomics in renal transplantation-quo vadis? | Q27024418 | ||
| miR-127 protects proximal tubule cells against ischemia/reperfusion: identification of kinesin family member 3B as miR-127 target | Q27320810 | ||
| MicroRNA expression data reveals a signature of kidney damage following ischemia reperfusion injury | Q27327194 | ||
| Treatment of chronic kidney disease | Q27694623 | ||
| Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review | Q28652412 | ||
| Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
| The urine microRNA profile may help monitor post-transplant renal graft function | Q30411597 | ||
| Identification of biomarkers to assess organ quality and predict posttransplantation outcomes. | Q30414752 | ||
| Reduced expression of inflammatory genes in deceased donor kidneys undergoing pulsatile pump preservation | Q30427250 | ||
| The microRNA-processing enzyme dicer maintains juxtaglomerular cells | Q30433053 | ||
| Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity. | Q30585385 | ||
| OPTN/SRTR 2012 Annual Data Report: kidney | Q30724491 | ||
| Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis | Q33367473 | ||
| Cellular and molecular mechanisms in kidney fibrosis | Q33685938 | ||
| Memory T-cell-specific therapeutics in organ transplantation | Q33708195 | ||
| miR-200b precursor can ameliorate renal tubulointerstitial fibrosis | Q33737756 | ||
| DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease | Q33740666 | ||
| From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment | Q33787798 | ||
| Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. | Q33834320 | ||
| Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells | Q33865856 | ||
| Identification of a microRNA signature of renal ischemia reperfusion injury | Q34069581 | ||
| Defining the acute kidney injury and repair transcriptome | Q34180380 | ||
| MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. | Q34203975 | ||
| Diagnosis and prevention of chronic kidney allograft loss | Q34224452 | ||
| Histone deacetylase: a potential therapeutic target for fibrotic disorders | Q34257607 | ||
| Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy | Q34259063 | ||
| Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation | Q34289498 | ||
| On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. | Q34312520 | ||
| Analytical approaches to metabolomics and applications to systems biology | Q34340503 | ||
| Small and Long Regulatory RNAs in the Immune System and Immune Diseases | Q34368789 | ||
| The primary glomerulonephritides: a systems biology approach | Q34462626 | ||
| MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis | Q34468508 | ||
| Epigenetic regulation of pluripotency and differentiation | Q34498966 | ||
| MicroRNA-24 antagonism prevents renal ischemia reperfusion injury | Q34568822 | ||
| DNA methylation dynamics in blood after hematopoietic cell transplant | Q34602752 | ||
| Long non-coding RNAs and control of gene expression in the immune system | Q34616243 | ||
| Long non-coding RNAs: modulators of nuclear structure and function | Q37589709 | ||
| The complexities of microRNA regulation: mirandering around the rules | Q37607457 | ||
| The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant | Q37621568 | ||
| Preimplant histologic acute tubular necrosis and allograft outcomes | Q37621573 | ||
| Epigenetic events during B lymphocyte development. | Q37624372 | ||
| A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury | Q37629173 | ||
| Noninvasive diagnosis of acute rejection of renal allografts | Q37637948 | ||
| DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study | Q37668895 | ||
| Molecular pathways involved in loss of graft function in kidney transplant recipients. | Q37724869 | ||
| Improved transplantation outcome by epigenetic changes | Q37752924 | ||
| Infection and chronic allograft dysfunction | Q37813410 | ||
| Consequences of transplant quality on chronic allograft nephropathy | Q37813412 | ||
| Assessment of kidney organ quality and prediction of outcome at time of transplantation | Q37832966 | ||
| Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? | Q37849269 | ||
| MicroRNAs and epigenetics | Q37852129 | ||
| The role of natural killer cells in human solid organ and tissue transplantation | Q37853788 | ||
| Brain death induced renal injury. | Q37854398 | ||
| Epigenetic mechanisms and kidney diseases. | Q37861834 | ||
| Signals and combinatorial functions of histone modifications | Q37870190 | ||
| Local and global epigenetic regulation of V(D)J recombination | Q37893054 | ||
| Regulatory T cell therapy for the induction of clinical organ transplantation tolerance | Q37932810 | ||
| The coin toss of B cells in rejection and tolerance: danger versus defense | Q37950550 | ||
| Mutational determinants of epigenetic instablity in myeloid malignancies | Q37979960 | ||
| Epigenetics: time to translate into transplantation | Q37995936 | ||
| Protein and peptide biomarkers in organ transplantation | Q38021513 | ||
| Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. | Q38027504 | ||
| Chronic renal allograft injury: early detection, accurate diagnosis and management. | Q38035660 | ||
| Developing microRNA therapeutics: approaching the unique complexities. | Q38036732 | ||
| Biomarker discovery in transplantation--proteomic adventure or mission impossible? | Q38054291 | ||
| NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury | Q38054458 | ||
| The role of promoter hypermethylation in fibroblast activation and fibrogenesis | Q38055432 | ||
| miRNA-transcription factor interactions: a combinatorial regulation of gene expression | Q38075480 | ||
| T-cell memory differentiation: insights from transcriptional signatures and epigenetics. | Q38076478 | ||
| Has the survival of the graft improved after renal transplantation in the era of modern immunosuppression? | Q38077924 | ||
| Long non-coding RNAs: challenges for diagnosis and therapies | Q38079887 | ||
| Development and maintenance of regulatory T cells | Q38092234 | ||
| Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation | Q38097126 | ||
| Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents | Q38099873 | ||
| Histone modifications for human epigenome analysis | Q38112246 | ||
| Epigenetic modulation of the immune function: a potential target for tolerance | Q38117237 | ||
| Regulatory T cells in the immunodiagnosis and outcome of kidney allograft rejection | Q38120752 | ||
| Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer | Q38128454 | ||
| Contribution of genetics and epigenetics to progression of kidney fibrosis | Q38131466 | ||
| Urine microRNAs as potential noninvasive biomarkers in urologic cancers. | Q38137530 | ||
| Acute kidney injury in kidney transplantation | Q38146486 | ||
| Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology | Q38152226 | ||
| MicroRNAs with a role in gene regulation and in human diseases | Q38160370 | ||
| Modulation of epigenetic regulators and cell fate decisions by miRNAs | Q38166839 | ||
| FibromiRs: translating molecular discoveries into new anti-fibrotic drugs | Q38190254 | ||
| Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs. | Q38196176 | ||
| Chromatin dynamics in kidney development and function. | Q38210944 | ||
| Epigenetics: the neglected key to minimize learning and memory deficits in Down syndrome. | Q38214416 | ||
| Molecular biology of brain metastasis | Q38216231 | ||
| Complement as a multifaceted modulator of kidney transplant injury | Q38217273 | ||
| The effect of ischemia/reperfusion on the kidney graft | Q38218153 | ||
| Innate and adaptive immune responses subsequent to ischemia-reperfusion injury in the kidney | Q38221985 | ||
| Diabetic nephropathy--emerging epigenetic mechanisms | Q38227252 | ||
| Epigenetics of hematopoietic stem cell aging and disease | Q38235887 | ||
| The role of genetics and epigenetics in the pathogenesis of systemic sclerosis | Q38241234 | ||
| An update on epigenetics and childhood respiratory diseases | Q38242704 | ||
| Advances in the profiling of DNA modifications: cytosine methylation and beyond | Q38243577 | ||
| Ischemic epigenetics and the transplanted kidney | Q38306439 | ||
| Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells | Q38307188 | ||
| Update on epigenetics in allergic disease. | Q38310584 | ||
| Smad3-mediated upregulation of miR-21 promotes renal fibrosis | Q38388639 | ||
| Gene expression patterns in deceased donor kidneys developing delayed graft function after kidney transplantation. | Q38514211 | ||
| MicroRNA‑21 inhibits SMAD7 expression through a target sequence in the 3' untranslated region and inhibits proliferation of renal tubular epithelial cells | Q38986403 | ||
| Robust global microRNA expression profiling using next-generation sequencing technologies | Q39032588 | ||
| The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway | Q39123810 | ||
| Gender-specific role of HDAC11 in kidney ischemia- and reperfusion-induced PAI-1 expression and injury | Q39154615 | ||
| Ischaemia-reperfusion injury: a major protagonist in kidney transplantation | Q39295523 | ||
| Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development | Q39338522 | ||
| Histone deacetylase inhibitors suppress natural killer cell cytolytic activity | Q40161252 | ||
| Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction | Q42782232 | ||
| Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury | Q43244113 | ||
| TGF-β-induced signaling circuit loops mediated by microRNAs as new therapeutic targets for renal fibrosis? | Q43423735 | ||
| Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients | Q44164490 | ||
| Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? | Q44573200 | ||
| Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers | Q44927347 | ||
| Gene expression changes are associated with loss of kidney graft function and interstitial fibrosis and tubular atrophy: diagnosis versus prediction. | Q44962520 | ||
| Novel markers in zero-hour kidney biopsies indicate graft quality and clinical outcome | Q45142240 | ||
| New opportunities for organ transplantation research: epigenetics is likely to be an important determinant of the host immune response | Q45382914 | ||
| Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. | Q45964495 | ||
| Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation | Q46608101 | ||
| Ischemia- reperfusion injury and its influence on the epigenetic modification of the donor kidney genome | Q46897225 | ||
| Protection of NAD(P)H:quinone oxidoreductase 1 against renal ischemia/reperfusion injury in mice | Q46975578 | ||
| The complex world of kidney microRNAs. | Q48821153 | ||
| Epigenetic mechanisms in development and disease. | Q50743330 | ||
| Demethylation of the RORC2 and IL17A in human CD4+ T lymphocytes defines Th17 origin of nonclassic Th1 cells. | Q50850916 | ||
| Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. | Q50968365 | ||
| Molecular dysfunctions in acute rejection after renal transplantation revealed by integrated analysis of transcription factor, microRNA and long noncoding RNA. | Q50984036 | ||
| Epigenetic reprogramming of the RORC locus during in vitro expansion is a distinctive feature of human memory but not naïve Treg. | Q51013890 | ||
| Epigenetic modification of the human CCR6 gene is associated with stable CCR6 expression in T cells. | Q51024074 | ||
| High-throughput approaches for microRNA expression analysis. | Q51770581 | ||
| DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. | Q52924279 | ||
| TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction. | Q54608975 | ||
| The Transcriptome of the Implant Biopsy Identifies Donor Kidneys at Increased Risk of Delayed Graft Function | Q57014398 | ||
| Early activation of fibrogenesis in transplanted kidneys: A study on serial renal biopsies | Q58004292 | ||
| Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia–reperfusion injury by microRNA-dependent reprogramming of resident renal cells | Q58831473 | ||
| Intragraft Regulatory T Cells in Protocol Biopsies Retain Foxp3 Demethylation and Are Protective Biomarkers for Kidney Graft Outcome | Q59491274 | ||
| MicroRNA expression profiles predictive of human renal allograft status | Q37146807 | ||
| Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21 | Q37184698 | ||
| Genomic analysis in nephrology--towards systems biology and systematic medicine? | Q37202423 | ||
| MicroRNA and nephropathy: emerging concepts | Q37221074 | ||
| From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review). | Q37313310 | ||
| Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function? | Q37342577 | ||
| Epigenetic reprogramming: is deamination key to active DNA demethylation? | Q37393053 | ||
| Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells | Q37396074 | ||
| Beyond genetics: epigenetic code in chronic kidney disease | Q37402757 | ||
| Epigenetic mechanisms of regulation of Foxp3 expression | Q37412329 | ||
| Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. | Q37417291 | ||
| Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis | Q37420213 | ||
| Essential concept of transplant immunology for clinical practice | Q37428551 | ||
| Ischemia and reperfusion--from mechanism to translation | Q37455225 | ||
| Chronic allograft nephropathy--a clinical syndrome: early detection and the potential role of proliferation signal inhibitors | Q37589673 | ||
| Epigenetics in kidney development and renal disease | Q34633331 | ||
| Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection | Q34663943 | ||
| miR-21 in ischemia/reperfusion injury: a double-edged sword? | Q34790075 | ||
| Advances of genomic science and systems biology in renal transplantation: a review | Q34862535 | ||
| TGF-beta signaling in renal disease | Q34869314 | ||
| Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue | Q34922714 | ||
| A comprehensive overview of Infinium HumanMethylation450 data processing | Q34976889 | ||
| An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition | Q34977307 | ||
| Methylation determines fibroblast activation and fibrogenesis in the kidney | Q35019643 | ||
| Identifying biomarkers as diagnostic tools in kidney transplantation | Q35049801 | ||
| Dynamic regulation of transcriptional states by chromatin and transcription factors. | Q35068557 | ||
| Epigenetics: deciphering its role in diabetes and its chronic complications | Q35068854 | ||
| Activation-induced cytidine deaminase mediates central tolerance in B cells | Q35105238 | ||
| Late kidney allograft loss: what we know about it, and what we can do about it | Q35153318 | ||
| DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation | Q35266180 | ||
| Identification of a microRNA signature in renal fibrosis: role of miR-21. | Q35326035 | ||
| Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat. | Q35541039 | ||
| Noncoding RNA as therapeutic targets for hepatocellular carcinoma. | Q35592207 | ||
| Systems biology of kidney diseases | Q35619034 | ||
| Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis | Q35715738 | ||
| Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients | Q35834994 | ||
| Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant | Q35853304 | ||
| Pretransplant transcriptome profiles identify among kidneys with delayed graft function those with poorer quality and outcome | Q35876866 | ||
| A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells | Q35915947 | ||
| Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance | Q36024233 | ||
| Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation. | Q36102469 | ||
| MicroRNAs and fibrosis | Q36103009 | ||
| Protocol biopsy of donor kidney in renal transplantation. | Q36122303 | ||
| MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy. | Q36124250 | ||
| The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation | Q36390497 | ||
| A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network | Q36478003 | ||
| Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference | Q36666806 | ||
| Epigenetic regulation of BMP7 in the regenerative response to ischemia | Q36736738 | ||
| miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease | Q36967821 | ||
| HDAC inhibitors in kidney development and disease | Q37115414 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney transplantation | Q740909 |
| epigenetics | Q26939 | ||
| P304 | page(s) | 23-38 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Epigenetics in Kidney Transplantation: Current Evidence, Predictions, and Future Research Directions | |
| P478 | volume | 100 |
| Q104289866 | Advances of miRNAs in kidney graft injury |
| Q38683990 | Application of Ultrasound Elastography for Chronic Allograft Dysfunction in Kidney Transplantation. |
| Q38760291 | BET Proteins: An Approach to Future Therapies in Transplantation. |
| Q47104864 | Essential role of microRNA-650 in the regulation of B-cell CLL/lymphoma 11B gene expression following transplantation: A novel mechanism behind the acute rejection of renal allografts |
| Q38929359 | From HLA typing to anti-HLA antibody detection and beyond: The road ahead |
| Q40987197 | Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation. |
| Q55492541 | LCK as a Potential Therapeutic Target for Acute Rejection after Kidney Transplantation: A Bioinformatics Clue. |
| Q93063013 | Predictors of Early and Late Mortality in Older Kidney Transplant Recipients |
| Q38788555 | Presence of Cytotoxic Extracellular Histones in Machine Perfusate of Donation After Circulatory Death Kidneys |
| Q92594523 | Regulation of Endothelial-to-Mesenchymal Transition by MicroRNAs in Chronic Allograft Dysfunction |
| Q41239969 | Renal Protection Mediated by Hypoxia Inducible Factor-1α Depends on Proangiogenesis Function of miR-21 by Targeting Thrombospondin 1. |
| Q30276752 | Systems Biology in Kidney Transplantation: The Application of Multi-Omics to a Complex Model |
| Q61816301 | Unveiling the Role of DNA Methylation in Kidney Transplantation: Novel Perspectives toward Biomarker Identification |
| Q47822802 | Using omics to explore complications of kidney transplantation. |
| Q37419464 | Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation |
Search more.